Clinical Trials Sponsored by MEI Pharma, Inc.
Total 2469 results
-
Astellas Pharma IncCompletedPatients With Impaired Renal Function and HaemodialysisJapan
-
Astellas Pharma IncCompletedIrritable Bowel SyndromeJapan
-
Astellas Pharma IncCompletedIrritable Bowel SyndromeJapan
-
Astellas Pharma IncCompletedMelanoma | Non-Hodgkin's Lymphoma | Prostate CancerUnited States
-
Astellas Pharma IncTerminatedLymphoma, Large-Cell, Diffuse | Lymphoma, B-Cell RefractoryFrance, Spain, United States, Canada
-
Astellas Pharma IncCompletedKidney TransplantationBelgium, Italy, Taiwan, France, South Africa, Turkey, Germany, United Kingdom, Hungary, Czech Republic, Romania, Sweden, Poland, Israel
-
Astellas Pharma IncCompletedRenal Insufficiency | Chronic Kidney Disease | HyperphosphatemiaJapan
-
Astellas Pharma IncCompletedRenal Insufficiency | Chronic Kidney Disease | Renal DialysisJapan
-
Astellas Pharma IncCompletedLiver Transplantation | Kidney TransplantationIndia
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompleted
-
Akros Pharma Inc.CompletedDiabetes MellitusUnited States
-
Astellas Pharma IncCompletedDermatitis, AtopicUnited States, Canada
-
Astellas Pharma IncCompletedDermatitis, AtopicFrance, Germany, Spain, Belgium, Netherlands, Finland, Austria, United Kingdom, Italy, Czech Republic, Switzerland, Portugal, Denmark
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveUnited States
-
Astellas Pharma IncCompletedCandidiasis, OralSouth Africa, Brazil, Peru
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveFrance, United Kingdom, Belgium, Germany, Spain, Portugal, Greece, Russian Federation, Czech Republic, Poland, Hungary, Italy, Slovakia, Egypt
-
ZS Pharma, Inc.Terminated
-
Astellas Pharma IncCompletedKeratoconjunctivitis | ConjunctivitisJapan
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedDermatitis, AtopicPoland, Czech Republic, Hungary
-
Astellas Pharma IncCompletedLiver TransplantationBelgium, Germany, Italy, Switzerland, Spain, Denmark, United Kingdom, Hungary, Finland, Sweden, Poland
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedUlcerative ColitisJapan
-
Astellas Pharma IncCompletedLiver TransplantationItaly
-
Astellas Pharma IncCompletedMyasthenia GravisJapan
-
Astellas Pharma IncCompletedLower Urinary Tract Symptoms | Prostatic HyperplasiaFrance, Poland, Germany, Spain, Finland, Netherlands, Russian Federation, Czech Republic, Hungary, Norway, Denmark, Slovakia, Sweden, Austria, Portugal, United Kingdom
-
Astellas Pharma IncCompletedTransplantationFrance, Italy, Poland, Germany, Spain, Belgium, Switzerland, Finland, Czech Republic, Hungary, Austria, Denmark, Sweden
-
Astellas Pharma IncCompletedA Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on DialysisRenal Insufficiency | Chronic Kidney Disease | HyperphosphatemiaJapan
-
Astellas Pharma IncCompletedTransplantationFrance, Spain, Germany, United Kingdom, Ireland, Poland
-
Astellas Pharma IncCompletedLiver TransplantationFrance, Italy, Poland, Belgium, Spain, Germany, Switzerland, Canada, Finland, Brazil, Czech Republic, Australia, Norway, Sweden, United Kingdom, Ireland
-
Astellas Pharma IncCompletedKidney TransplantationAustralia, France, United Kingdom, Germany, Spain, Argentina, South Africa, Switzerland, Canada, Finland, Greece, Netherlands, Brazil, Belgium, Poland, Hungary, Czech Republic, Austria, Ireland, Italy, Mexico, Norway, Sweden
-
Antares Pharma Inc.CompletedUrinary Frequency | Urge Urinary IncontinenceUnited States
-
Astellas Pharma IncTerminatedKidney TransplantationUnited States
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncTerminatedBladder FunctionUnited States
-
SignPath Pharma, Inc.Completed
-
Antares Pharma Inc.Completed
-
Astellas Pharma IncCompletedHealthy | Plasma Concentration of ASP1941Japan
-
Astellas Pharma IncCompletedPsoriasisUnited States, Bulgaria, Latvia
-
Astellas Pharma IncTerminated
-
Astellas Pharma IncCompletedHealthy Subjects | Pharmacokinetics | CardiovascularUnited Kingdom
-
Astellas Pharma IncCompletedKidney TransplantationUnited States, Canada, Brazil
-
Astellas Pharma IncCompletedPost-marketing Study to Evaluate the Effect of Mirabegron on the Plasma Concentration of TolterodineHealthy | Pharmacokinetics of Mirabegron and TolterodineJapan
-
Astellas Pharma IncTerminatedInvasive AspergillosisPoland, Belgium, Spain, France, Germany, Colombia, Brazil, Argentina, Hungary, Czech Republic, Croatia, Italy
-
Astellas Pharma IncCompletedHealthy Volunteers | Pharmacokinetics of MirabegronFrance
-
Astellas Pharma IncCompletedHealthy Volunteer | Pharmacokinetics of YM178Japan
-
Astellas Pharma IncCompletedOveractive Bladder | PharmacokineticsFrance
-
Astellas Pharma IncCompletedAny Solid Tumor or LymphomaUnited States, Belgium, United Kingdom